Impact of Pharmaceutical Care Interventions on the Quality of Life of Group of Hypertensive Patients

Abstract

Studies have shown that pharmaceutical care interventions have the potential of reducing hospital stay and drug therapy problems; it can also improve patients' quality of life. The primary objectives of this study was to show how pharmaceutical care interventions could resolve actual drug therapy problems and prevent potential drug therapy problems; also, to assess the change in the quality of life of hypertensive patients after such interventions. An uncontrolled prospective study was done. Hypertensive patients were recruited at the Medical Out-patients department (MOD) of Central Hospital Warri. Initially 104 patients were recruited, however, a total of 65 eligible patients were eventually used to asses for quality of life. Data were obtained using data collection forms; blood pressure was monitored using a sphygmomanometer, and patients were scheduled for follow up periodically for 6 months.Clinical outcomes and humanistic outcomes were assessed using the SF12 health survey form, and subsequently scored. DTPs were identified, case by case. All identified DTPs were reported in the patients" pharmaceutical care data collection forms. Relevant descriptive and inferential statistics on data collected were performed. 65 patients were eventually followed up, 21.5% of them were males while 78.5% were females, with 72.3% of them aged 51years and above. Most of them (61.5%) had a family history of high blood pressure; 40% of them were diagnosed to have hypertension and diabetes; only 18.5% of them obtained their prescription re-fill from the hospital pharmacy. At the end of the study, a significant difference in the systolic blood pressure of the patients was discovered and there was a statistically significant association between DTP resolved/prevented and the pharmaceutical care intervention (p<0.001). The correlation between DTPs resolved/ prevented was significant in two domains of quality of life measure -the mental component summary (MCS), and the bodily pain domain. Pharmaceutical care provided to hypertensive patients in a secondary health facility in Warri, Nigeria, resolved some of the drug therapy problems identified and improved patients" quality of life.

Effectiveness of a pharmacist‐led educational intervention on health outcomes in hypertension management at community pharmacies in Nigeria: A two‐arm parallel single‐blind randomized controlled trial

“…The same tool has been used in a Nigerian population before, but in the southern region of the country. 35 The findings of the study showed that there was an improvement in some of the domains of the QoL of the patients assessed at the end of the study: all domains in the MCS and bodily pain. Although the results of the present study revealed that there was no statistically significant difference between the study arms at the end of the study, clinical relevance cannot be ruled out.…”

“…This study utilized the quality metric short form, a 12‐item tool, to assess the participants' QoL. The same tool has been used in a Nigerian population before, but in the southern region of the country 35 . The findings of the study showed that there was an improvement in some of the domains of the QoL of the patients assessed at the end of the study: all domains in the MCS and bodily pain.…”

“…The possibility of a clinical impact due to the intervention of the present study is further strengthened by the fact that patients performed independently in both components of the QoL tool: physical and mental. The ability to measure these 2 separate components of QoL has made the SF‐12 a tool of choice in interventional studies 35 …”

“…The ability to measure these 2 separate components of QoL has made the SF-12 a tool of choice in interventional studies. 35…”

"An Assessment of Collaboration Between Members of the Healthcare Team in Providing Medication Therapy Management (MTM)"

“…This is more evident in developed countries where entire organizations are shifting to a team-based approach to health care, which requires collaboration between all health care providers to provide the best, most efficient and most cost-effective services to patients. The role of each health care provider is being re-examined and redefined, so that patients can be seen in the timeliest manner and by the most qualified provider Smith et al [1].…”